Cargando…
Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial
BACKGROUND: Type 2 diabetes mellitus (T2DM) with obesity is a glycolipid metabolism disorder, which makes hypoglycaemic treatment more complex and increases the proportion of multidrug combinations. In addition, patients are more prone to adverse reactions and gradually lose compliance with treatmen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116828/ https://www.ncbi.nlm.nih.gov/pubmed/37076915 http://dx.doi.org/10.1186/s13063-023-07301-4 |
_version_ | 1785028507521253376 |
---|---|
author | Liu, Zhidong Zhang, Kepei Zhang, Jianpin Wang, Fei Zhou, Yang Wang, Lin Wang, Miao Zhang, Yi Zhou, Shigao |
author_facet | Liu, Zhidong Zhang, Kepei Zhang, Jianpin Wang, Fei Zhou, Yang Wang, Lin Wang, Miao Zhang, Yi Zhou, Shigao |
author_sort | Liu, Zhidong |
collection | PubMed |
description | BACKGROUND: Type 2 diabetes mellitus (T2DM) with obesity is a glycolipid metabolism disorder, which makes hypoglycaemic treatment more complex and increases the proportion of multidrug combinations. In addition, patients are more prone to adverse reactions and gradually lose compliance with treatment. Previous clinical trials have demonstrated that Daixie Decoction granules (DDG) can reduce body weight and blood lipids and improve the quality of life of T2DM with obesity. But there are a lack of further evaluations for the efficacy and safety of DDG combined with metformin. METHODS/DESIGN: The study is designed as a multicentre, randomized, double-blind, placebo-controlled clinical trial. Participants who meet the Nathrow criteria will be randomly assigned to the intervention group and control group (n (1) = n (2) = 133). Based on a unified diet control and exercise therapy, the intervention group will be treated with DDG and metformin, and the control group will be treated with DDG placebo and metformin. All subjects will receive a 6-month treatment followed by a 6-month follow-up. Effective rate of a 1% decrease in HbA1c and 3% decrease in body weight will serve as the primary outcome. The secondary outcome include fasting plasma glucose, blood lipids, C-peptides, insulin, inflammatory factors, insulin resistance index (HOMA-IR) and the subcutaneous and visceral fat content in the upper abdomen measured by MRI. Blood routine, urine routine, stool routine, liver and kidney function, EKG and other safety indicators and major adverse reactions were monitored during total treatment and follow-up time. DISCUSSION: We aimed to determine the efficacy and safety of DDG combined with metformin for the treatment of T2DM patients with obesity. TRIAL REGISTRATION: Trial registration: ChiCTR, ChiCTR2000036290. Registered 22 August 2014, http://www.chictr.org.cn/showprojen.aspx? proj=59001 |
format | Online Article Text |
id | pubmed-10116828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101168282023-04-21 Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial Liu, Zhidong Zhang, Kepei Zhang, Jianpin Wang, Fei Zhou, Yang Wang, Lin Wang, Miao Zhang, Yi Zhou, Shigao Trials Study Protocol BACKGROUND: Type 2 diabetes mellitus (T2DM) with obesity is a glycolipid metabolism disorder, which makes hypoglycaemic treatment more complex and increases the proportion of multidrug combinations. In addition, patients are more prone to adverse reactions and gradually lose compliance with treatment. Previous clinical trials have demonstrated that Daixie Decoction granules (DDG) can reduce body weight and blood lipids and improve the quality of life of T2DM with obesity. But there are a lack of further evaluations for the efficacy and safety of DDG combined with metformin. METHODS/DESIGN: The study is designed as a multicentre, randomized, double-blind, placebo-controlled clinical trial. Participants who meet the Nathrow criteria will be randomly assigned to the intervention group and control group (n (1) = n (2) = 133). Based on a unified diet control and exercise therapy, the intervention group will be treated with DDG and metformin, and the control group will be treated with DDG placebo and metformin. All subjects will receive a 6-month treatment followed by a 6-month follow-up. Effective rate of a 1% decrease in HbA1c and 3% decrease in body weight will serve as the primary outcome. The secondary outcome include fasting plasma glucose, blood lipids, C-peptides, insulin, inflammatory factors, insulin resistance index (HOMA-IR) and the subcutaneous and visceral fat content in the upper abdomen measured by MRI. Blood routine, urine routine, stool routine, liver and kidney function, EKG and other safety indicators and major adverse reactions were monitored during total treatment and follow-up time. DISCUSSION: We aimed to determine the efficacy and safety of DDG combined with metformin for the treatment of T2DM patients with obesity. TRIAL REGISTRATION: Trial registration: ChiCTR, ChiCTR2000036290. Registered 22 August 2014, http://www.chictr.org.cn/showprojen.aspx? proj=59001 BioMed Central 2023-04-19 /pmc/articles/PMC10116828/ /pubmed/37076915 http://dx.doi.org/10.1186/s13063-023-07301-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Liu, Zhidong Zhang, Kepei Zhang, Jianpin Wang, Fei Zhou, Yang Wang, Lin Wang, Miao Zhang, Yi Zhou, Shigao Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title | Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title_full | Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title_fullStr | Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title_full_unstemmed | Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title_short | Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
title_sort | effectiveness and safety of daixie decoction granules combined with metformin for the treatment of t2dm patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116828/ https://www.ncbi.nlm.nih.gov/pubmed/37076915 http://dx.doi.org/10.1186/s13063-023-07301-4 |
work_keys_str_mv | AT liuzhidong effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT zhangkepei effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT zhangjianpin effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT wangfei effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT zhouyang effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT wanglin effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT wangmiao effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT zhangyi effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial AT zhoushigao effectivenessandsafetyofdaixiedecoctiongranulescombinedwithmetforminforthetreatmentoft2dmpatientswithobesitystudyprotocolforarandomizeddoubleblindedplacebocontrolledmulticentreclinicaltrial |